Bayer Balance Sheet Health
Financial Health criteria checks 2/6
Bayer has a total shareholder equity of €33.1B and total debt of €43.8B, which brings its debt-to-equity ratio to 132.3%. Its total assets and total liabilities are €116.3B and €83.2B respectively. Bayer's EBIT is €7.8B making its interest coverage ratio 12. It has cash and short-term investments of €10.6B.
Key information
132.3%
Debt to equity ratio
€43.77b
Debt
Interest coverage ratio | 12x |
Cash | €10.59b |
Equity | €33.08b |
Total liabilities | €83.18b |
Total assets | €116.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BAYZ.F's short term assets (€37.6B) exceed its short term liabilities (€29.5B).
Long Term Liabilities: BAYZ.F's short term assets (€37.6B) do not cover its long term liabilities (€53.7B).
Debt to Equity History and Analysis
Debt Level: BAYZ.F's net debt to equity ratio (100.3%) is considered high.
Reducing Debt: BAYZ.F's debt to equity ratio has increased from 88.8% to 132.3% over the past 5 years.
Debt Coverage: BAYZ.F's debt is not well covered by operating cash flow (11.7%).
Interest Coverage: BAYZ.F's interest payments on its debt are well covered by EBIT (12x coverage).